Strategic Partnerships Potential collaboration with home health providers and urgent care networks to offer integrated molecular and toxicology testing, leveraging recent Amedisys partnership as a model to expand geographic reach.

Acquisition & Growth capitalize on growth opportunities following the Infinity Laboratories acquisition by PCL in 2022 to cross-sell enhanced panels and leverage expanded reference lab capabilities to win larger client contracts.

Toxicology & Infectious Target hospitals and clinics expanding infectious disease and toxicology testing, offering high-precision molecular panels, rapid reporting, and pharmacogenetics insights to support treatment decisions.

SMB Market Focus Position as a scalable, mid-market laboratory partner suitable for smaller health systems and independent hospitals, highlighting cost-effective, robust reporting to win mid-sized accounts and referrals.

Digital Footprint Leverage existing tech stack and online channels to drive demand by optimizing Google Analytics eCommerce data, LinkedIn advertising, and secure web forms to capture leads from target providers seeking advanced diagnostic services.